Litigation: SEC Obtains Final Judgments Against Florida Microcap CEO, Consultant for Fraud
May 16, 2024
May 16, 2024
WASHINGTON, May 16 -- The Securities and Exchange Commission issued the following litigation release (No. 2:18-cv-5459; E.D.N.Y filed Sept. 28, 2018) involving Nutra Pharma Corp. et al:
* * *
On May 13, 2024, the U.S. District Court for the Eastern District of New York entered final consent judgments against Erik ("Rik") Deitsch, the former CEO of microcap issuer Nutra Pharma Corporation ("Nutra Pharma"), and Sean McManus, a consultant for Nutra Phar . . .
* * *
On May 13, 2024, the U.S. District Court for the Eastern District of New York entered final consent judgments against Erik ("Rik") Deitsch, the former CEO of microcap issuer Nutra Pharma Corporation ("Nutra Pharma"), and Sean McManus, a consultant for Nutra Phar . . .